Drug Surveillance System for Tracking Drug Exposure Trends

The Emergency Department Drug Surveillance (EDDS) system uses electronic health records and urinalysis to track drug use among emergency department patients, providing critical data on drug trends to healthcare providers and policymakers.

Background

The ongoing opioid epidemic, marked by the surge in synthetic opioids like fentanyl, poses a significant threat to public health. Emergency departments (EDs) are often the first point of contact for individuals experiencing overdoses, highlighting the need for accurate and timely data on drug exposures to guide treatment and harm reduction strategies. This data is crucial for informing healthcare providers, policymakers, and public health officials in their efforts to combat the crisis effectively.

Current approaches to tracking drug exposures among ED patients often rely on clinical records or lagging indicators, which can be unreliable and incomplete. Patients may not disclose all substances used, and physicians may not always order comprehensive drug screenings. This lack of accurate data hinders the ability to identify emerging drug trends, assess the true prevalence of specific substances, and develop targeted interventions to address the evolving nature of the opioid epidemic.

Technology

The Emergency Department Drug Surveillance (EDDS) System is a national monitoring framework that leverages electronic health records (EHRs) and urinalysis data to track drug use among emergency department patients. Covering 50 hospitals across 17 states, EDDS collects semiannual EHR datasets, including drug test results and clinical information. Additionally, the system conducts expanded urinalyses on de-identified patient samples to detect a broad spectrum of substances. The EDDS database houses approximately 1,000,000 EHRs and over 3,600 specimens retested for 200-500 substances. This data has been instrumental in implementing routine fentanyl testing in several hospitals and states.

\n\n EDDS is differentiated by its unique approach to drug surveillance. It is the only national system that combines EHR data with urinalysis results, providing a more comprehensive view of drug exposure than clinical records alone. This approach is crucial because patients and physicians may not always be aware of all the substances ingested. By analyzing both EHR and urinalysis data, EDDS can identify drug trends, such as the prevalence of fentanyl and xylazine, with greater accuracy. This information is vital for healthcare providers updating drug testing protocols and policymakers addressing drug-related health crises.

Benefits

  • Tracks drug exposure among emergency department patients using electronic health records and urinalysis results.
  • Provides critical data on drug trends, such as the prevalence of fentanyl and xylazine in overdose cases.
  • Supports healthcare providers in updating drug testing protocols.
  • Informs policy decisions aimed at addressing drug-related health crises.

Applications

  • Drug trend monitoring
  • Overdose detection
  • Public health policy
  • Hospital drug testing
  • Harm reduction programs

Additional info

A detailed technical description of the Emergency Department Drug Surveillance (EDDS) System: EDDS is a national monitoring framework utilizing electronic health records (EHRs) and urinalysis to track drug use among emergency department patients. It collects semiannual datasets from hospital EHRs, including drug test results and clinical information. The system also conducts expanded urinalyses on de-identified patient urine samples to detect a wide range of substances.